Cerevel Therapeutics Holdings Inc (CERE) USD0.0001
Sell:$42.47Buy:$43.00
$0.40 (0.95%)
- This stock can be held in a
Stocks and Shares ISASell:$42.47
Buy:$43.00
Change:$0.40 (0.95%)
$0.40 (0.95%)Prices delayed by at least 15 minutes
Sell:$42.47
Buy:$43.00
Change:$0.40 (0.95%)
$0.40 (0.95%)Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 1 April 2024 | Neavelle Anthony (Tony) ColesChairman/CEO | Sell Option/Award related | 50,000 | $42.33 | $2,116,640.00 | 15,638 |
| 4 March 2024 | Neavelle Anthony (Tony) ColesChairman/CEO | Sell Option/Award related | 50,000 | $41.01 | $2,050,550.00 | 15,638 |
| 29 February 2024 | Neavelle Anthony (Tony) ColesChairman/CEO | Sell Option/Award related | 50,000 | $41.16 | $2,057,890.00 | 15,638 |
| 7 February 2024 | Neavelle Anthony (Tony) ColesChairman/CEO | Sell Tax related | 2,506 | $41.54 | $104,109.51 | 15,638 |
| 7 February 2024 | John J RengerChief Level Officer | Sell Tax related | 2,161 | $41.54 | $89,776.80 | 6,370 |
| 2 January 2024 | Neavelle Anthony (Tony) ColesChairman/CEO | Sell Option/Award related | 50,000 | $42.24 | $2,111,815.00 | 2,704 |
| 26 December 2023 | Ramiro SanchezOther Level A | Sell Option/Award related | 10,000 | $42.47 | $424,700.00 | 14,673 |
| 22 December 2023 | Kenneth A. (Ken) DiPietroChief Level Officer | Sell Option/Award related | 8,000 | $41.45 | $331,608.00 | 24,663 |
| 20 December 2023 | Kenneth A. (Ken) DiPietroChief Level Officer | Sell Tax related | 6,256 | $41.42 | $259,143.54 | 24,663 |
| 20 December 2023 | Mark BodenraderChief Accounting Officer | Sell Tax related | 7,889 | $41.42 | $326,787.62 | 17,724 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 16 October 2023 | BAIN CAPITAL INVESTORS LLC20% Owner | Buy Regular purchase transaction | 5,480,052 | $22.81 | $124,999,986.12 | 65,679,781 |
| 16 October 2023 | PERCEPTIVE ADVISORS LLCPrivate Equity | Buy Regular purchase transaction | 876,808 | $22.81 | $19,999,990.48 | 10,794,876 |
| 15 June 2023 | NOVALIS LIFESCIENCES LLCVenture Capital | Sell Regular sell transaction (market) | 200,000 | $34.43 | $6,886,000.00 | 402,326 |
| 1 April 2024 | Neavelle Anthony (Tony) ColesChairman/CEO | Sell Option/Award related | 50,000 | $42.33 | $2,116,640.00 | 15,638 |
| 2 January 2024 | Neavelle Anthony (Tony) ColesChairman/CEO | Sell Option/Award related | 50,000 | $42.24 | $2,111,815.00 | 2,704 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.